Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection

Clinical trial NCT06409702 · RECRUITING

Trial details

NCT number: NCT06409702
Sponsor: The First Affiliated Hospital of Soochow University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Newly Diagnosed High Risk MRD Multiple Myeloma

Start date: 2024-06-12
Primary completion: 2027-11-30
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.